Related Experiment Video
Updated: Feb 13, 2026

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
Published on: January 12, 2024
Pros and cons of different therapeutic antibody formats for recombinant antivenom development
Andreas H Laustsen1, José María Gutiérrez2, Cecilie Knudsen1
1Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
Abstract:
Antibody technologies are being increasingly applied in the field of toxinology. Fuelled by the many advances in immunology, synthetic biology, and antibody research, different approaches and antibody formats are being investigated for the ability to neutralize animal toxins. These different molecular formats each have their own therapeutic characteristics. In this review, we provide an overview of the advances made in the development of toxin-targeting antibodies, and discuss the benefits and drawbacks of different antibody formats in relation to their ability to neutralize toxins, pharmacokinetic features, propensity to cause adverse reactions, formulation, and expression for research and development (R&D) purposes and large-scale manufacturing. A research trend seems to be emerging towards the use of human antibody formats as well as camelid heavy-domain antibody fragments due to their compatibility with the human immune system, beneficial therapeutic properties, and the ability to manufacture these molecules cost-effectively.
Related Concept Videos
Zygotic Development And Stem Cell Formation
Recombinant DNA
Viral Recombination
Homologous Recombination
Overview of Transposition and Recombination
Therapeutic Index

